🇺🇸 FDA
Patent

US 12180206

Aceclidine derivatives, compositions thereof and methods of use thereof

granted A61KA61K31/4748A61K47/40

Quick answer

US patent 12180206 (Aceclidine derivatives, compositions thereof and methods of use thereof) held by LENZ THERAPEUTICS OPERATIONS, INC. expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LENZ THERAPEUTICS OPERATIONS, INC.
Grant date
Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/4748, A61K47/40, A61K9/0048, A61K9/08